Insights from Eli Lilly’s TRAILBLAZER-ALZ Program
March 16, 2023
John R. Sims, senior vice president and head of global development, and Dawn A. Brooks, director of clinical development; both with Eli Lilly discuss the design of the TRAILBLAZER-ALZ program.